DexCom
DXCM
#895
Rank
$25.58 B
Marketcap
$65.25
Share price
0.62%
Change (1 day)
-19.45%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2025 (TTM): $0.97 Billion USD

According to DexCom's latest financial reports the company's current earnings are $4.51 Billion USD. In 2024 the company made an earning of $0.72 Billion USD a decrease over its 2023 earnings that were of $0.73 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $0.97 B34.34%
2024 $0.72 B-0.37%
2023 $0.73 B78.13%
2022 $0.41 B47.34%
2021 $0.27 B-10.11%
2020 $0.30 B88.27%
2019 $0.16 B-258.48%
2018 -$0.11 Billion189.94%
2017 -$35.8 Million-44.24%
2016 -$64.2 Million12.43%
2015 -$57.1 Million165.58%
2014 -$21.5 Million-25.61%
2013 -$28.9 Million-48.11%
2012 -$55.7 Million24.5%
2011 -$44.74 Million
2008 -$52.83 Million13.18%
2007 -$46.68 Million-5.36%
2006 -$49.33 Million52.08%
2005 -$32.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Edwards Lifesciences
EW
$1.70 B 74.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
$1.88 B 92.84%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical
WST
$0.60 B-38.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-$0.21 Billion-120.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
$6.40 B 554.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Abbott Laboratories
ABT
$8.13 B 732.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B 3,212.47%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-$1.14 Billion-216.18%๐Ÿ‡บ๐Ÿ‡ธ USA